Clinuvel Drug Shows Efficacy in Vitiligo, But Some Asian Patients Wary
Clinuvel's Scenesse has shown promise in treating vitiligo in a Phase II trial, but recruitment has been slow because some patients of Asian ethnicity are concerned about overall skin darkening.
You may also be interested in...
The topical version of Jakafi will move into Phase III later this year for the autoimmune disease after a strong Phase II showing.
France is exploring the use of hydroxychloroquine and lopinavir/ritonavir in COVID-19, but only in hospitalized patients and in clinical trials, and has banned all exports of the products to avoid possible shortages.
Efforts are under way in the UK on many fronts to develop new treatments and vaccines for coronavirus infection, including researching new uses of existing products and clinical trials of new vaccines.